The 2019 Bioanalysis Rising Star Award finalists have been announced! Meet Justin Mak (Stanford Health Care, CA, USA) your 2019 BRSA finalist.
Find out more about the role of exosomes in flow cytometry studies and future pharmacological developments in this interview with Joyce Slusser (KCAS; KS, USA).
Find out more about current challenges and recent developments in seen in the field of flow cytometry in this interview with Clara Brando and Ted Baginski (Eurofins; MO, USA).
In this interview, Rafiq Islam (Celerion) discusses the impact FDA guidance for industry on bioanalytical method validation has had on biomarker research in recent years and shares his thoughts on technologies that will change biomarker research in the future.
In this interview, David Lanham (Eurofins) discusses his work using flow cytometry in early clinical stage work and the progress that has been made to regulate and standardize the field.
Find out more about the challenges associated with gene therapy and what the future may hold for the field in this interview with Hugh Davis (Frontage Laboratories; PA, USA).
An author’s perspective: George Jaskiw on quantification of phenolic acid metabolites in humans by LC–MS
We talk to George Jaskiw about his work on quantification of phenolic acid metabolites in humans by LC–MS in this interview as part of our author’s perspective series.
Overcoming the challenges in bioanalysis of oligonucleotide-based therapies and relevance to the clinical development plan
Hugh M. Davis Chief Business Officer, Frontage Laboratories, Inc., Exton, Pennsylvania (PA, USA) As CBO…
We talk to Vellalore Kakkanaiah about his work using flow cytometry in adoptive cell therapy in this interview as part of our author’s perspective series.
In this Bioanalysis Zone interview, Pegah Jalili (MilliporeSigma) discusses her current work in analytical R&D of biotherapeutic characterization and quantification, and what she thinks the future looks like for this field of bioanalysis.